Zimmer Biomet Holdings, Inc.
ZBHFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
7,679
Cost of Revenue
2,191
Gross Profit
5,487
Gross Margin
71.5%
Operating Income
1,286
Operating Margin
16.7%
Net Income
904
Net Margin
11.8%
EPS (Basic)
$4.45
EPS (Diluted)
$4.43
EBITDA
2,251
EBITDA Margin
29.3%
2023
12/31/2023
Revenue
7,394
Cost of Revenue
2,084
Gross Profit
5,310
Gross Margin
71.8%
Operating Income
1,278
Operating Margin
17.3%
Net Income
1,024
Net Margin
13.8%
EPS (Basic)
$4.91
EPS (Diluted)
$4.88
EBITDA
2,220
EBITDA Margin
30.0%
2022
12/31/2022
Revenue
6,940
Cost of Revenue
2,020
Gross Profit
4,920
Gross Margin
70.9%
Operating Income
696
Operating Margin
10.0%
Net Income
231
Net Margin
3.3%
EPS (Basic)
$1.10
EPS (Diluted)
$1.10
EBITDA
1,495
EBITDA Margin
21.5%
2021
12/31/2021
Revenue
6,827
Cost of Revenue
1,960
Gross Profit
4,867
Gross Margin
71.3%
Operating Income
860
Operating Margin
12.6%
Net Income
402
Net Margin
5.9%
EPS (Basic)
$1.93
EPS (Diluted)
$1.91
EBITDA
1,645
EBITDA Margin
24.1%
2020
12/31/2020
Revenue
6,128
Cost of Revenue
1,824
Gross Profit
4,303
Gross Margin
70.2%
Operating Income
83
Operating Margin
1.4%
Net Income
-139
Net Margin
-2.3%
EPS (Basic)
$-0.67
EPS (Diluted)
$-0.67
EBITDA
1,005
EBITDA Margin
16.4%